Global Testosterone Undecanoate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Testosterone Undecanoate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Testosterone undecanoate, sold under the brand names Nebido, Aveed, and Andriol among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men. It is also used in hormone therapy for transgender men. It is taken by mouth two to three times per day with food or given by injection into muscle once every 12 weeks or so.
Testosterone Undecanoate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Testosterone Undecanoate market is projected to reach US$ 827.4 million in 2029, increasing from US$ 564 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Demand from Primary Hypogonadism and Hypogonadotropic Hypogonadism are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Testosterone Undecanoate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Testosterone Undecanoate key manufacturers include Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, Taro Pharmaceutical, Cipla, Zhejiang Xianju Pharmaceutical and Zhejiang Medicine Co., etc. Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme are top 3 players and held % sales share in total in 2022.
Testosterone Undecanoate can be divided into Injection and Oral, etc. Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Testosterone Undecanoate is widely used in various fields, such as Primary Hypogonadism, Hypogonadotropic Hypogonadism and Late-Onset Hypogonadism,, etc. Primary Hypogonadism provides greatest supports to the Testosterone Undecanoate industry development. In 2022, global % sales of Testosterone Undecanoate went into Primary Hypogonadism filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Testosterone Undecanoate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine Co.
Segment by Type
Injection
Oral
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Testosterone Undecanoate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Testosterone Undecanoate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Testosterone Undecanoate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Testosterone Undecanoate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Testosterone Undecanoate introduction, etc. Testosterone Undecanoate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Testosterone Undecanoate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Testosterone Undecanoate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Testosterone Undecanoate market is projected to reach US$ 827.4 million in 2029, increasing from US$ 564 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Demand from Primary Hypogonadism and Hypogonadotropic Hypogonadism are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Testosterone Undecanoate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Testosterone Undecanoate key manufacturers include Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, Taro Pharmaceutical, Cipla, Zhejiang Xianju Pharmaceutical and Zhejiang Medicine Co., etc. Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme are top 3 players and held % sales share in total in 2022.
Testosterone Undecanoate can be divided into Injection and Oral, etc. Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Testosterone Undecanoate is widely used in various fields, such as Primary Hypogonadism, Hypogonadotropic Hypogonadism and Late-Onset Hypogonadism,, etc. Primary Hypogonadism provides greatest supports to the Testosterone Undecanoate industry development. In 2022, global % sales of Testosterone Undecanoate went into Primary Hypogonadism filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Testosterone Undecanoate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Bayer AG
Endo Pharmaceuticals
Merck Sharp & Dohme
Taro Pharmaceutical
Cipla
Zhejiang Xianju Pharmaceutical
Zhejiang Medicine Co.
Segment by Type
Injection
Oral
Segment by Application
Primary Hypogonadism
Hypogonadotropic Hypogonadism
Late-Onset Hypogonadism
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Testosterone Undecanoate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Testosterone Undecanoate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Testosterone Undecanoate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Testosterone Undecanoate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Testosterone Undecanoate introduction, etc. Testosterone Undecanoate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Testosterone Undecanoate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices